Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/11/2011
PIL Premique 0.625mg/5mg Coated Tablets.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 28/09/2011 and displayed until 11/11/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 14/07/2011 and displayed until 28/09/2011
Reasons for adding or updating:
  • Change of contra-indications
Updated on 20/04/2010 and displayed until 14/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 25/01/2010 and displayed until 20/04/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 29/05/2009 and displayed until 25/01/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 29/08/2008 and displayed until 29/05/2009
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 24/06/2008 and displayed until 29/08/2008
Reasons for adding or updating:
  • Change to packaging
  • Change to storage instructions
Updated on 08/11/2006 and displayed until 24/06/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
Updated on 10/02/2006 and displayed until 08/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to how the medicine works
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 14/04/2005 and displayed until 10/02/2006
Reasons for adding or updating:
  • Change from BAN to rINN
  • Change to storage instructions
  • Change to date of revision
Updated on 20/02/2004 and displayed until 14/04/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 19/11/2003 and displayed until 20/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 08/07/2002 and displayed until 19/11/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  medroxyprogesterone acetate
  oestrogens, conjugated